Federal Register Proposed rule: FDA is proposing to amend the final monograph for OTC sunscreen drug products as part of the agency’s ongoing review of OTC drug products. This amendment addresses formulation, labeling, and testing requirements for both ultraviolet B and ultraviolet A radiation protection. To view this proposed rule, click here.
